Half-year report · Q2
7747.TEDINET S100V8NQ
Period2024-07-01 → 2024-12-31
Filed2025-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥61.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Revenue | ¥107.5bn | 2023-07-01 → 2024-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥54.3bn | 2023-07-01 → 2023-12-31 | Cons. | Net sales |
| Operating income | ¥17.4bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Operating income | ¥13.5bn | 2023-07-01 → 2023-12-31 | Cons. | Operating income |
| Ordinary income | ¥16.8bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥22.0bn | 2023-07-01 → 2024-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.5bn | 2023-07-01 → 2023-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥16.9bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥13.4bn | 2023-07-01 → 2023-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥15.8bn | 2023-07-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.8bn | 2023-07-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Net income | ¥9.9bn | 2023-07-01 → 2023-12-31 | Cons. | Profit loss |
| Total assets | ¥190.1bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥191.6bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥169.1bn | at 2023-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥31.2bn | at 2024-12-31 | Cons. | Liabilities |
| Total liabilities | ¥39.7bn | at 2024-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥158.9bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥152.0bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥138.8bn | at 2023-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥37.6bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥35.7bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥37.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.7bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.5bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.9bn | at 2023-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥18.3bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥34.7bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥12.6bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥7.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥21.2bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.0bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥8.9bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥13.9bn | 2023-07-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥11.8bn | 2023-07-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥45.14 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥58.2 | 2023-07-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥36.15 | 2023-07-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 83.2% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.9% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.6% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥3.6bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥13.0bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥5.7bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥2.5bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥68.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥21.0bn |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2023-12-31 | −¥6.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2023-12-31 | −¥6.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2023-12-31 | −¥3.4bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥12.7bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥6.0bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥6.8bn |
| jpcrp040300-q2r_E02349-000Devicereportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥2.9bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue | 2023-07-01 → 2023-12-31 | ¥48.4bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | revenue external | 2023-07-01 → 2023-12-31 | ¥48.4bn |
| jpcrp040300-q2r_E02349-000Medicalreportable segment | segment profit | 2023-07-01 → 2023-12-31 | ¥14.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-07-01 → 2023-12-31 | ¥61.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-07-01 → 2023-12-31 | ¥54.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-07-01 → 2023-12-31 | ¥6.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-07-01 → 2023-12-31 | ¥16.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 478
| Item | Context | Value | Unit |
|---|---|---|---|
| Description issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | － | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)朝日インテック㈱ | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)愛知県瀬戸市暁町３番地100 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentQuarterInstant | Text · Plus | |
| Notes regarding allowances directly deducted from balances of assets (text) | CurrentQuarterInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |